Showing 91-100 of 574 results for "".
Therapeutics Focus: Corticosteroids
https://practicaldermatology.com/topics/psoriasis/therapeutics-focus-corticosteroids/21432/New products and pharmacologic developmentsJournal Club: Biologics for Young Children
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RCurrent Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.Pregnancy and Melanoma: What We Know About the Risks
https://practicaldermatology.com/topics/practice-management/pregnancy-and-melanoma-what-we-know-about-the-risks/21041/Against a backdrop of conflicting findings, a new study suggests a significant risk associated with melanoma during pregnancy.Inflamed Feelings: The Psychological Effects of Inflammatory Disorders
https://practicaldermatology.com/topics/psoriasis/PD0309_05-php/22859/Data suggest that children and adults suffering from chronic inflammatory skin diseases, such as eczema and psoriasis, are at higher risk for depression, anxiety, and other psychiatric illnesses.Cosmeceuticals Series, Part 2: Antioxidants
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-series-part-2-antioxidants/21395/The second article in this quarterly series examines how cosmeceuticals containing antioxidants can mitigate UV-induced damage.MOC Sparks Anger, Frustration in Physician Community
https://practicaldermatology.com/topics/practice-management/moc-sparks-anger-frustration-in-physician-community/20898/Anti-MOC advocates wonder why they cannot get a seat at the table to discuss changing the system.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.?Understand and Correct Common Claim Denials
https://practicaldermatology.com/topics/general-topics/PD0109_09-php/22896/A review of some common causes for claim denials identifies strategies for obtaining proper reimbursement.Understanding a New Method of Assessing Psoriasis Severity
https://practicaldermatology.com/columns/clinical-focus-1/understanding-a-new-method-of-assessing-psoriasis-severity/23157/New method aims to improve access to systemic psoriasis therapy.